Institut for Biomedicin

Ditte Demontis

Exploring genetic variation that influences brain methylation in attention-deficit/hyperactivity disorder

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Laura Pineda-Cirera, Universitat Pompeu Fabra, Barcelona, CIBER - Center for Biomedical Research Network
  • ,
  • Anu Shivalikanjli, Universitat Pompeu Fabra, Barcelona, Institut de Recerca Sant Joan de Déu
  • ,
  • Judit Cabana-Domínguez, Universitat Pompeu Fabra, Barcelona, CIBER - Center for Biomedical Research Network, Institut de Recerca Sant Joan de Déu
  • ,
  • Ditte Demontis
  • Veera M. Rajagopal
  • Anders D. Børglum
  • Stephen V. Faraone, State University of New York Upstate Medical University
  • ,
  • Bru Cormand, Universitat Pompeu Fabra, Barcelona, CIBER - Center for Biomedical Research Network, Institut de Recerca Sant Joan de Déu
  • ,
  • Noèlia Fernàndez-Castillo, Universitat Pompeu Fabra, Barcelona, CIBER - Center for Biomedical Research Network, Institut de Recerca Sant Joan de Déu

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder caused by an interplay of genetic and environmental factors. Epigenetics is crucial to lasting changes in gene expression in the brain. Recent studies suggest a role for DNA methylation in ADHD. We explored the contribution to ADHD of allele-specific methylation (ASM), an epigenetic mechanism that involves SNPs correlating with differential levels of DNA methylation at CpG sites. We selected 3896 tagSNPs reported to influence methylation in human brain regions and performed a case-control association study using the summary statistics from the largest GWAS meta-analysis of ADHD, comprising 20,183 cases and 35,191 controls. We observed that genetic risk variants for ADHD are enriched in ASM SNPs and identified associations with eight tagSNPs that were significant at a 5% false discovery rate (FDR). These SNPs correlated with methylation of CpG sites lying in the promoter regions of six genes. Since methylation may affect gene expression, we inspected these ASM SNPs together with 52 ASM SNPs in high LD with them for eQTLs in brain tissues and observed that the expression of three of those genes was affected by them. ADHD risk alleles correlated with increased expression (and decreased methylation) of ARTN and PIDD1 and with a decreased expression (and increased methylation) of C2orf82. Furthermore, these three genes were predicted to have altered expression in ADHD, and genetic variants in C2orf82 correlated with brain volumes. In summary, we followed a systematic approach to identify risk variants for ADHD that correlated with differential cis-methylation, identifying three novel genes contributing to the disorder.

OriginalsprogEngelsk
Artikelnummer242
TidsskriftTranslational Psychiatry
Vol/bind9
Nummer1
ISSN2158-3188
DOI
StatusUdgivet - dec. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 169339228